title: Activation of corticotropin releasing factor-containing neurons in the rat central amygdala and bed nucleus of the stria terminalis following exposure to two different anxiogenic stressors.
abstract: Rats exposed to the odor of a predator or to the elevated plus maze (EPM) express unique unconditioned fear behaviors. The extended amygdala has previously been demonstrated to mediate the response to both predator odor and the EPM. We seek to determine if divergent amygdalar microcircuits are associated with the different behavioral responses. The current experiments compared activation of corticotropin-releasing factor (CRF)-containing neuronal populations in the central amygdala and bed nucleus of the stria terminalis (BNST) of rats exposed to either the EPM (5 min) versus home cage controls, or predator (ferret) odor versus butyric acid, or no odor (30 min). Sections of the brains were prepared for dual-labeled immunohistochemistry and counts of c-Fos co-localized with CRF were made in the centrolateral and centromedial amygdala (CLA and CMA) as well as the dorsolateral (dl), dorsomedial (dm), and ventral (v) BNST. Ferret odor-exposed rats displayed an increase in duration and a decrease in latency of defensive burying versus control rats. Exposure to both predator stress and EPM induced neuronal activation in the BNST, but not the central amygdala, and similar levels of neuronal activation were seen in both the high and low anxiety groups in the BNST after EPM exposure. Dual-labeled immunohistochemistry showed a significant increase in the percentage of CRF/c-Fos co-localization in the vBNST of ferret odor-exposed rats compared to control and butyric acid-exposed groups as well as EPM-exposed rats compared to home cage controls. In addition, an increase in the percentage of CRF-containing neurons co-localized with c-Fos was observed in the dmBNST after EPM exposure. No changes in co-localization of CRF with c-Fos was observed with these treatments in either the CLA or CMA. These results suggest that predator odor and EPM exposure activates CRF neurons in the BNST to a much greater extent than CRF neurons of the central amygdala, and indicates unconditioned anxiogenic stimuli may activate unique anatomical circuits in the extended amygdala.
authors.affiliation: Department of Pharmacology, Physiology and Neuroscience, University of South Carolina School of Medicine, Columbia, SC, USA. Electronic address: ryan.butler@med.unc.edu.
authors.forename: Ryan K
authors.initials: RK
authors.lastname: Butler
authors.affiliation: Department of Pharmacology, Physiology and Neuroscience, University of South Carolina School of Medicine, Columbia, SC, USA.
authors.forename: Elisabeth M
authors.initials: EM
authors.lastname: Oliver
authors.affiliation: Department of Pharmacology, Physiology and Neuroscience, University of South Carolina School of Medicine, Columbia, SC, USA; WJB Dorn Veterans Affairs Medical Center, Columbia, SC,USA.
authors.forename: Amanda C
authors.initials: AC
authors.lastname: Sharko
authors.affiliation: Department of Pharmacology, Physiology and Neuroscience, University of South Carolina School of Medicine, Columbia, SC, USA.
authors.forename: Jeffrey
authors.initials: J
authors.lastname: Parilla-Carrero
authors.affiliation: Department of Pharmacology, Physiology and Neuroscience, University of South Carolina School of Medicine, Columbia, SC, USA.
authors.forename: Kris F
authors.initials: KF
authors.lastname: Kaigler
authors.affiliation: Department of Pharmacology, Physiology and Neuroscience, University of South Carolina School of Medicine, Columbia, SC, USA.
authors.forename: Jim R
authors.initials: JR
authors.lastname: Fadel
authors.affiliation: Department of Pharmacology, Physiology and Neuroscience, University of South Carolina School of Medicine, Columbia, SC, USA; WJB Dorn Veterans Affairs Medical Center, Columbia, SC,USA.
authors.forename: Marlene A
authors.initials: MA
authors.lastname: Wilson
mesh_terms: D000704:Analysis of Variance; D000818:Animals; D066274:Central Amygdaloid Nucleus / Q000473:pathology*; D003346:Corticotropin-Releasing Hormone / Q000378:metabolism*; D004195:Disease Models, Animal; D005239:Fear / Q000523:psychology; D008297:Male; D018782:Maze Learning / Q000502:physiology; D009474:Neurons / Q000378:metabolism*; D009812:Odorants; D016761:Oncogene Proteins v-fos / Q000378:metabolism; D011235:Predatory Behavior; D051381:Rats; D020318:Rats, Long-Evans; D012686:Septal Nuclei / Q000473:pathology*; D018709:Statistics, Nonparametric; D013315:Stress, Psychological / Q000473:pathology*
chemical_list: D016761:Oncogene Proteins v-fos; D003346:Corticotropin-Releasing Hormone
keywords: Amygdala; BNST; CRF; EPM; Predator odor
references.citation: J Neurosci. 2005 Jun 22;25(25):5998-6004
references.pmid: 15976089
references.citation: Prog Neurobiol. 1998 Jun;55(3):257-332
references.pmid: 9643556
references.citation: Ann N Y Acad Sci. 2003 Apr;985:472-5
references.pmid: 12724179
references.citation: Ann N Y Acad Sci. 1997 Jun 21;821:305-31
references.pmid: 9238214
references.citation: Neuroscience. 2011 Jan 13;172:314-28
references.pmid: 20955766
references.citation: Behav Brain Res. 2013 Apr 15;243:286-93
references.pmid: 23376701
references.citation: J Comp Neurol. 2000 Jul 10;422(4):533-55
references.pmid: 10861525
references.citation: Neuroscience. 1988 Oct;27(1):1-39
references.pmid: 3059226
references.citation: Eur J Neurosci. 2013 Apr;37(8):1357-67
references.pmid: 23368426
references.citation: Neuroscience. 2015 Mar 19;289:153-65
references.pmid: 25595987
references.citation: Exp Neurol. 2012 Nov;238(1):52-63
references.pmid: 22917777
references.citation: Nat Neurosci. 2014 Dec;17(12):1644-54
references.pmid: 25413091
references.citation: Neuropsychopharmacology. 2006 Jun;31(6):1227-40
references.pmid: 16123750
references.citation: Psychopharmacology (Berl). 2002 Mar;160(2):113-21
references.pmid: 11875628
references.citation: Neurosci Biobehav Rev. 2008 Sep;32(7):1267-76
references.pmid: 18619675
references.citation: Behav Brain Res. 2013 Oct 15;255:19-25
references.pmid: 23684554
references.citation: J Neurosci Methods. 1985 Aug;14(3):149-67
references.pmid: 2864480
references.citation: Nature. 2013 Apr 11;496(7444):224-8
references.pmid: 23515155
references.citation: Physiol Behav. 1992 Feb;51(2):277-85
references.pmid: 1557438
references.citation: Nat Neurosci. 2005 Sep;8(9):1263-8
references.pmid: 16116447
references.citation: Neuropsychopharmacology. 2008 Nov;33(12):2957-68
references.pmid: 18216773
references.citation: Proc Natl Acad Sci U S A. 2007 Mar 20;104(12):5163-8
references.pmid: 17360345
references.citation: Peptides. 1992 May-Jun;13(3):451-60
references.pmid: 1381826
references.citation: Behav Brain Res. 2013 Jul 1;248:85-93
references.pmid: 23583519
references.citation: Behav Brain Res. 2009 Sep 14;202(2):218-24
references.pmid: 19463704
references.citation: Neuroscience. 2012 Sep 27;221:21-7
references.pmid: 22766237
references.citation: Annu Rev Pharmacol Toxicol. 2004;44:525-57
references.pmid: 14744257
references.citation: Transl Psychiatry. 2014;4:e359
references.pmid: 24518397
references.citation: J Comp Neurol. 1999 Oct 11;413(1):113-28
references.pmid: 10464374
references.citation: Behav Neurosci. 2004 Apr;118(2):324-32
references.pmid: 15113258
references.citation: Front Neurosci. 2013 Aug 30;7:156
references.pmid: 24009552
references.citation: Brain Res. 2001 Jul 6;906(1-2):60-73
references.pmid: 11430862
references.citation: Neuropharmacology. 2012 Mar;62(4):1737-45
references.pmid: 22210331
references.citation: Ann N Y Acad Sci. 1993 Oct 29;697:53-60
references.pmid: 8257022
references.citation: Mol Psychiatry. 2013 Mar;18(3):308-19
references.pmid: 22290119
references.citation: Brain Struct Funct. 2008 Sep;213(1-2):29-42
references.pmid: 18528706
references.citation: J Neurosci. 2009 Aug 19;29(33):10357-61
references.pmid: 19692610
references.citation: Neuropsychopharmacology. 2005 Sep;30(9):1589-97
references.pmid: 15770236
references.citation: Prog Brain Res. 1996;107:461-84
references.pmid: 8782537
references.citation: Psychopharmacology (Berl). 2011 Feb;213(2-3):465-73
references.pmid: 20945065
references.citation: Alcohol Clin Exp Res. 2006 May;30(5):791-801
references.pmid: 16634847
references.citation: J Pharmacol Exp Ther. 2004 Nov;311(2):427-40
references.pmid: 15297468
references.citation: Front Neurosci. 2015 Aug 25;9:292
references.pmid: 26379483
references.citation: Neuropsychopharmacology. 2000 Jan;22(1):77-88
references.pmid: 10633493
references.citation: Neurosci Biobehav Rev. 2006;30(4):472-96
references.pmid: 16243397
references.citation: Brain Res. 2009 Sep 8;1288:79-87
references.pmid: 19615352
references.citation: Neuropsychopharmacology. 2010 Jan;35(1):105-35
references.pmid: 19693004
references.citation: Transl Psychiatry. 2013;3:e289
references.pmid: 23900312
references.citation: Proc Natl Acad Sci U S A. 2001 Sep 25;98(20):11042-6
references.pmid: 11572966
references.citation: Ann N Y Acad Sci. 1999 Jun 29;877:309-38
references.pmid: 10415657
references.citation: Pharmacol Biochem Behav. 2006 Nov;85(3):545-54
references.pmid: 17109943
references.citation: Nature. 2011 Mar 17;471(7338):358-62
references.pmid: 21389985
references.citation: Brain Res. 2004 Oct 29;1025(1-2):139-51
references.pmid: 15464754
references.citation: Neuroscience. 2011 Feb 23;175:133-44
references.pmid: 21146592